Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Male pattern baldness does not cause an increased risk of prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Older men and those with outdoor jobs are at higher risk for skin cancer; early full-body skin checks are recommended for early detection.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Women with alopecia may have a higher chance of getting thyroid cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Docetaxel treatment for breast cancer can cause permanent hair loss.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Dietary phytoestrogens do not significantly affect testicular cancer risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.